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Abstract
Background: Catatonia is a neuropsychiatric syndrome with motor and behavioural symptoms. Though usually
occuring in patients with schizophrenia and mood disorders, this syndrome may also be associated with
neurological diseases or general medical conditions. Few cases of catatonia associated with autoimmune disorders
have been described.
Case presentation: Here, we report the case of a 27-year-old woman diagnosed with Hashimoto’s encephalitis
(HE) who attempted suicide and infanticide by defenestration. As she presented risk factors for postpartum
psychosis, she was treated principally with antipsychotics. Despite adequate treatment for psychosis, symptoms
worsened and she developed catatonia. Complementary investigations showed elevated titres of anti-thyroglobulin
and anti-thyroperoxidase antibodies (200 and 10 times, respectively, as compared to normal levels) and
electroencephalography were suggestive of encephalopathy. In the presence of an otherwise unexplained
neuropsychiatric condition, HE was suspected and oral prednisolone was introduced. Psychiatric symptoms
improved dramatically within 72 h and the patient was still free of any symptom 3 years later.
Conclusion: Catatonia of organic aetiology should always be considered before a psychiatric aetiology especially in
case of clinical worsening in spite of adequate psychotropic treatment. To our knowledge, this is the first
description of catatonia associated with HE.
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Background
Catatonia is a neuropsychiatric syndrome with motor
and behavioural symptoms occurring in approximately
8 % of patients admitted for psychiatric illness such as
schizophrenia or mood disorders [1]. Seven to 45 % of
catatonias are “organic catatonias” that is, catatonia sec-
ondary to a general medical condition [1–4]. Among
them, some cases of catatonia associated with auto-
immune diseases have been described in systemic lupus
erythematosus, anti-NMDAR (N-methyl-d-aspartate
receptor) encephalitis [5–8], paraneoplasic syndrome
[7, 9, 10], PANDAS (Pediatric Autoimmune Neuro-
psychiatric Disorder) [11] and in other rare syndromes like
Wilson disease [12]. First line recommended treatementr
in catatonia are benzodiazepine and ECT [13] but, in case
of SLE and anti-NMDAR encephalitis in adults, etiological
treatment, respectively plasma exchange and immu-
noglobulin perfusion associated with corticosteroid, is an
efficient option avoiding using ECT and psychotropic
drugs [14, 15]. Here we present a case highlighting that, as
psychiatric symptoms can be prominent in encephalop-
athy, the presence of catatonia associated with psychotic
features can be a misleading presentation for an under-
lying organic aetiology.* Correspondence: laurence.lalanne@chru-strasbourg.fr
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Case presentation
In 2009, a 27-year-old woman was admitted to our psy-
chiatric department. She had been found by emergency
response firemen, sitting with her 8-month-old twin
babies on the window ledge of her 9th floor apartment
tossing personal effects into the air.
The patient had no prior personal or family psychiatric
history. She was of Algerian origin and had arrived in
France 18 months earlier. Her husband was unemployed,
drug-dependent, and was rarely present at home. It had
been her first pregnancy, and she had given birth to two
girls via caesarean section, due to uterine haemorrhage
during the 35th week of amenorrhoea.
Upon admission, an examination found fluctuating
psychomotor agitation, anxiety, emotional lability, and
impulsivity. The patient had incoherent speech, persecu-
tory delusions, auditory hallucinations, and was disoriented
in time and space. According to her family, symptoms had
appeared three months earlier and had progressively wors-
ened. She was not known to be taking any medications nor
did she suffer from substance abuse. Considering the clin-
ical picture and because of the presence of classical risk
factors (first-time mother with multiple births associated
with obstetrical complications, recent immigration, father
of the children barely present), post-partum psychosis was
firstly suspected even though the delayed onset of psychi-
atric symptoms 5 to 8 months after birth was longer than
what is usually admitted for such a diagnosis [16]. As a
consequence, oral risperidone 2 mg daily and cyamema-
zine 30 mg daily were introduced. Forty-eight hours later,
symptoms worsened, and the patient presented with per-
manent auditory hallucinations, psychomotor instability,
as well as aggressive behaviour alternating with mutism,
negativism, stereotypic gestures and diffuse rigidity with
catalepsy. A vesperal aggravation was noted. According to
DSM-IV [17] and DSM-5 [18] criteria, catatonia was diag-
nosed. Oral lorazepam was introduced and progressively
increased until 12.5 mg daily. Because the clinical picture
worsened and to avoid an evolution towards malignant
catatonia, antipsychotics were stopped and complemen-
tary investigations were conducted.
Electroencephalography (EEG) showed a widespread
slowing of background activity without sharp-waves,
suggestive of encephalopathy. Brain imaging including
CT-scan, magnetic resonance imaging (MRI) scan, and
single photon emission computed tomography (SPECT-
scan) were all normal. The patient was euthyroid but
had elevated titres of anti-thyroglobulin (TGAB) and
anti-thyroperoxidase (TPOAB) antibodies (200 and 10
times compared to normal, respectively). Cerebrospinal
fluid (CSF) examination revealed normal cell count, pro-
tein, and glucose levels. CSF cultures were negative and
TGAB and TPOAB titres in the CSF were normal. Thy-
roid echography showed a heterogeneous gland without
any sign of inflammation. No other abnormality was
found from further testing, including blood tests for regu-
lar auto-immune disorders, serological tests for herpes
simplex virus, cytomegalovirus, viral hepatitis B and C,
human immunodeficiency virus, syphilis, as well as blood
sampling for vitamins B 12, PP, and ceruloplasmin.
Hashimoto’s encephalopathy (HE) was suspected given
the association of high concentrations of anti-thyroid
antibodies and the presence of an otherwise unexplained
neuropsychiatric condition. Although medication with
risperidone 2 mg daily, cyamemazine 30 mg daily, and
eventually lorazepam 12.5 mg daily, was ongoing, no
clinical amelioration was observed. Therefore, oral pred-
nisolone was introduced at 60 mg daily. It was quickly
followed by a dramatic improvement of the clinical pic-
ture; within 72 h, the patient was again oriented in time
and space, and auditory hallucinations, as well as catato-
nia, disappeared. A follow-up EEG returned normal.
Corticosteroid treatment was maintained at a dosage of
60 mg daily for a month before being progressively de-
creased and stopped within a year. In 2013, after three
years of follow up, the patient still remained free of any
psychiatric symptom.
Discussion
Here, we describe a case of attempted infanticide and
suicide at the onset of catatonia. The literature report
increased risk of suicide and infanticide in catatonia
especially of psychiatric origin [19, 20]. Due to the pre-
dominance of psychiatric symptoms and the presence of
multiple risk factors, our initial diagnosis was post-
partum psychosis. However, treatment resistance made
us suspect a catatonia of organic origin. In catatonia, a
causality assessment score (CAUS) has been proposed
by Consoli et al. (2012) [21]. This score takes into account
the presence of similar cases described in the literature,
the presence of clinical, biological and paraclinical symp-
toms, and the response of the patient to the specific treat-
ment related to the suspected medical condition. When
applied to our clinical case, the score is 7/10, clearly favor-
ing an organic origin. HE is very probable in our patient
given high titers of anti-thyroid antibodies and the rapid
normalization of her clinical symptoms and EEG once
prednisolone was introduced [22–27]. It must be noted
that neither abnormal brain imaging nor the presence of
anti-thyroid antibodies in the CSF are necessarily required
for HE diagnosis [25]. Additionally, the thyroid status may
vary from normal to pathological among patients with
HE [23–25].
Hashimotos’encephalopathy is a rare syndrome, first
described by Brain et al. in 1966 [28]. It is suspected
whenever symptoms of acute or subacute encephalopathy
are associated with high serum levels of anti-thyroid anti-
bodies [18–21]. Because it lacks specific markers and is a
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clinically heterogeneous syndrome, HE remains an elusive
nosologic entity [18–21]. Clinical manifestations include
confusion, coma, stroke-like episodes, seizures, psychosis,
dementia, myoclonus and myelopathy [22–26]. The
pathophysiology of HE remains poorly understood:
proposed mechanisms include cerebral vasculitis and
neuronal reaction mediated by antibodies [29]. Recent
publications suggested that an insufficiency of cere-
bral blood flow, especially the in left prefrontal cortex
and anterior cingulate areas, due to vasculitis causes
the neuropsychiatric symptoms in HE, like psychosis,
consciousness disturbance [30] and mood disorders
[31]. Besides, the litterature showed a link between de-
pression and antithyroid antibodies regardless of thyroid
status, even after adjustment of psycho-social determi-
nants of depression [32]. However, it is still not known
whether antibodies in HE may play a direct role in brain
dysfunction especially as the level of circulating auto-
antibodies is not correlated with the severity of clinical
manifestations or with response to treatment. Moreover,
antithyroid antibodies can be elevated in a significant
percentage of the normal population and in other thyroid
disorders [25]. Laske et al (2005) reported a case of severe
depression associated with HE [26] and Babtain (2010)
reported a case of HE as late onset depression with psych-
otic features [33]. Both interpretated psychiatric symp-
toms as resulting from encephalopathy associated with
autoimmune thyroid disease. Both of cases rapidly and
dramatically improved under prednisolone, just as was
seen with our clincial case. Favorable response to cortico-
steroids and association with other autoimmune diseases
in HE point to inflammatory or autoimmune dysfunction
[26, 29, 32–34] that may also underlie the pathophysiology
of associated psychiatric symptoms such as depression,
psychosis and catatonia. It is consistent with the current
hypothesis of autoimmune and inflammatory pathophysi-
ology of mood and psychotic disorders [34, 35].
Conclusion
As psychiatric symptoms can be prominent in encephal-
opathy, they could potentially be misleading and point to
catatonia of psychiatric origin. However, an organic aeti-
ology should be always considered, especially in the
absence of any mental disorder history. Hashimoto’s
encephalopathy is a difficult diagnosis, especially when the
thyroid hormonal status is normal. Clinicians should
therefore think about dosing thyroid antibodies when con-
fronted with catatonia. More generally, a multidisciplinary
diagnosis approach with psychiatrists, internists and neu-
rologists is recommended in any case of catatonia [36].
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